SLC22A10
gene geneOn this page
Also known as OAT5hOAT5
Summary
SLC22A10 (solute carrier family 22 member 10 (gene/pseudogene), HGNC:18057) is a protein-coding gene on chromosome 11q12.3, encoding Solute carrier family 22 member 10 (Q63ZE4).
Predicted to enable transmembrane transporter activity. Predicted to be involved in organic anion transport. Predicted to be located in membrane.
Source: NCBI Gene 387775 — RefSeq curated summary.
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 91 total
- MANE Select transcript:
NM_001039752
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18057 |
| Approved symbol | SLC22A10 |
| Name | solute carrier family 22 member 10 (gene/pseudogene) |
| Location | 11q12.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | OAT5, hOAT5 |
| Ensembl gene | ENSG00000184999 |
| Ensembl biotype | protein_coding |
| OMIM | 607580 |
| Entrez | 387775 |
Gene structure
Transcript identifiers
Ensembl transcripts: 14 — 11 protein_coding, 1 retained_intron, 1 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay
ENST00000332793, ENST00000525620, ENST00000526800, ENST00000532724, ENST00000533483, ENST00000682643, ENST00000861889, ENST00000861890, ENST00000861891, ENST00000861892, ENST00000861893, ENST00000861894, ENST00000861895, ENST00000861896
RefSeq mRNA: 1 — MANE Select: NM_001039752
NM_001039752
CCDS: CCDS41661
Canonical transcript exons
ENST00000332793 — 10 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001326877 | 63302329 | 63302543 |
| ENSE00002149469 | 63289903 | 63290567 |
| ENSE00002167060 | 63311007 | 63311783 |
| ENSE00003461553 | 63299514 | 63299629 |
| ENSE00003472647 | 63298920 | 63299043 |
| ENSE00003480177 | 63297559 | 63297727 |
| ENSE00003512279 | 63291540 | 63291643 |
| ENSE00003538690 | 63297303 | 63297457 |
| ENSE00003627189 | 63304108 | 63304216 |
| ENSE00003684597 | 63304686 | 63304889 |
Expression profiles
Bgee: expression breadth broad, 67 present calls, max score 87.72.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1324 / max 66.2833, expressed in 9 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 114788 | 0.0535 | 6 |
| 114787 | 0.0405 | 7 |
| 114786 | 0.0271 | 6 |
| 114789 | 0.0113 | 5 |
Top tissues by expression
109 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| liver | UBERON:0002107 | 87.72 | gold quality |
| right lobe of liver | UBERON:0001114 | 85.19 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 80.82 | silver quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 78.45 | silver quality |
| quadriceps femoris | UBERON:0001377 | 70.35 | gold quality |
| cerebellar vermis | UBERON:0004720 | 67.75 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 63.77 | gold quality |
| thymus | UBERON:0002370 | 63.06 | silver quality |
| primary visual cortex | UBERON:0002436 | 60.33 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 59.31 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 58.75 | gold quality |
| right frontal lobe | UBERON:0002810 | 58.51 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 49.98 | gold quality |
| cerebral cortex | UBERON:0000956 | 49.06 | gold quality |
| temporal lobe | UBERON:0001871 | 46.83 | gold quality |
| amygdala | UBERON:0001876 | 46.59 | gold quality |
| frontal cortex | UBERON:0001870 | 45.77 | gold quality |
| lung | UBERON:0002048 | 45.05 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 44.20 | gold quality |
| lower esophagus | UBERON:0013473 | 44.19 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 43.92 | gold quality |
| sural nerve | UBERON:0015488 | 43.82 | gold quality |
| corpus callosum | UBERON:0002336 | 43.53 | silver quality |
| putamen | UBERON:0001874 | 43.52 | gold quality |
| nucleus accumbens | UBERON:0001882 | 43.31 | gold quality |
| cortex of kidney | UBERON:0001225 | 41.16 | gold quality |
| placenta | UBERON:0001987 | 40.81 | gold quality |
| brain | UBERON:0000955 | 40.44 | gold quality |
| kidney | UBERON:0002113 | 39.97 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 39.83 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.39 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): HNF1A
miRNA regulators (miRDB)
61 targeting SLC22A10, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-LET-7F-2-3P | 99.98 | 70.98 | 2588 |
| HSA-MIR-1185-1-3P | 99.98 | 71.04 | 2593 |
| HSA-MIR-1185-2-3P | 99.98 | 71.04 | 2593 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-548N | 99.98 | 71.94 | 4170 |
| HSA-MIR-548AB | 99.95 | 71.31 | 3488 |
| HSA-MIR-559 | 99.95 | 72.28 | 3609 |
| HSA-MIR-548A-5P | 99.94 | 71.27 | 3482 |
| HSA-MIR-548AD-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AE-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AK | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AM-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AP-5P | 99.94 | 71.14 | 3489 |
| HSA-MIR-548AQ-5P | 99.94 | 71.34 | 3426 |
| HSA-MIR-548AR-5P | 99.94 | 71.28 | 3515 |
| HSA-MIR-548AS-5P | 99.94 | 71.22 | 3482 |
| HSA-MIR-548AU-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AY-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548B-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548BB-5P | 99.94 | 71.27 | 3509 |
| HSA-MIR-548C-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548D-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548H-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548I | 99.94 | 71.25 | 3481 |
| HSA-MIR-548J-5P | 99.94 | 71.14 | 3489 |
| HSA-MIR-548O-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548W | 99.94 | 71.24 | 3488 |
| HSA-MIR-548Y | 99.94 | 71.28 | 3514 |
Literature-anchored findings (GeneRIF, showing 1)
- Illuminating the function of the orphan transporter, SLC22A10, in humans and other primates. (PMID:38782905)
Cross-species orthologs
50 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | slc22a4 | ENSDARG00000005335 |
| danio_rerio | oatx | ENSDARG00000019713 |
| danio_rerio | si:dkey-166k12.1 | ENSDARG00000054690 |
| danio_rerio | slc22a15 | ENSDARG00000055445 |
| danio_rerio | si:dkey-119m7.4 | ENSDARG00000071049 |
| danio_rerio | si:dkey-119m7.8 | ENSDARG00000096654 |
| drosophila_melanogaster | Orct | FBGN0019952 |
| drosophila_melanogaster | CG15221 | FBGN0030331 |
| drosophila_melanogaster | Balat | FBGN0033778 |
| drosophila_melanogaster | CG4630 | FBGN0033809 |
| drosophila_melanogaster | CG5592 | FBGN0035645 |
| drosophila_melanogaster | CG10486 | FBGN0035647 |
| drosophila_melanogaster | SLC22A | FBGN0037140 |
| drosophila_melanogaster | CG7458 | FBGN0037144 |
| drosophila_melanogaster | CG14691 | FBGN0037829 |
| drosophila_melanogaster | CG14855 | FBGN0038260 |
| drosophila_melanogaster | CG14856 | FBGN0038261 |
| drosophila_melanogaster | CG14857 | FBGN0038262 |
| drosophila_melanogaster | CG12783 | FBGN0038448 |
| drosophila_melanogaster | CG7333 | FBGN0038715 |
| drosophila_melanogaster | CG7342 | FBGN0038716 |
| drosophila_melanogaster | CG17751 | FBGN0038717 |
| drosophila_melanogaster | CG17752 | FBGN0038718 |
| drosophila_melanogaster | CG16727 | FBGN0038719 |
| drosophila_melanogaster | CG6231 | FBGN0038720 |
| drosophila_melanogaster | CG4465 | FBGN0038750 |
| drosophila_melanogaster | CG4462 | FBGN0038752 |
| drosophila_melanogaster | CG4459 | FBGN0038753 |
| drosophila_melanogaster | CG6356 | FBGN0039178 |
| drosophila_melanogaster | CG3690 | FBGN0040350 |
| drosophila_melanogaster | CG31103 | FBGN0051103 |
| drosophila_melanogaster | CG31106 | FBGN0051106 |
| drosophila_melanogaster | CG31272 | FBGN0051272 |
| drosophila_melanogaster | CG33233 | FBGN0053233 |
| drosophila_melanogaster | CG33234 | FBGN0053234 |
| drosophila_melanogaster | Orct2 | FBGN0086365 |
| drosophila_melanogaster | CG42269 | FBGN0259164 |
| drosophila_melanogaster | CG44098 | FBGN0264907 |
| caenorhabditis_elegans | WBGENE00003837 | |
| caenorhabditis_elegans | oct-1 | WBGENE00003842 |
| caenorhabditis_elegans | WBGENE00003843 | |
| caenorhabditis_elegans | WBGENE00006220 | |
| caenorhabditis_elegans | WBGENE00008110 | |
| caenorhabditis_elegans | WBGENE00011456 | |
| caenorhabditis_elegans | WBGENE00014127 | |
| caenorhabditis_elegans | WBGENE00015088 | |
| caenorhabditis_elegans | WBGENE00017751 | |
| caenorhabditis_elegans | WBGENE00019408 | |
| caenorhabditis_elegans | WBGENE00020701 | |
| caenorhabditis_elegans | WBGENE00044455 |
Paralogs (22): SLC22A16 (ENSG00000004809), SLC22A17 (ENSG00000092096), SLC22A2 (ENSG00000112499), SLC22A7 (ENSG00000137204), SLC22A23 (ENSG00000137266), SLC22A14 (ENSG00000144671), SLC22A3 (ENSG00000146477), SLC22A8 (ENSG00000149452), SLC22A9 (ENSG00000149742), SVOPL (ENSG00000157703), SLC22A15 (ENSG00000163393), SVOP (ENSG00000166111), SLC22A11 (ENSG00000168065), SLC22A13 (ENSG00000172940), SLC22A1 (ENSG00000175003), SLC22A25 (ENSG00000196600), SLC22A4 (ENSG00000197208), SLC22A5 (ENSG00000197375), SLC22A24 (ENSG00000197658), SLC22A12 (ENSG00000197891), SLC22A6 (ENSG00000197901), SLC22A31 (ENSG00000259803)
Protein
Protein identifiers
Solute carrier family 22 member 10 — Q63ZE4 (reviewed: Q63ZE4)
Alternative names: Organic anion transporter 5
All UniProt accessions (4): Q63ZE4, A0A804HHY1, E9PIT2, E9PMM0
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Membrane.
Tissue specificity. Detected in fetal and adult liver, and in adult kidney.
Similarity. Belongs to the major facilitator (TC 2.A.1) superfamily. Organic cation transporter (TC 2.A.1.19) family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q63ZE4-1 | 1 | yes |
| Q63ZE4-2 | 2 |
RefSeq proteins (1): NP_001034841* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR005828 | MFS_sugar_transport-like | Family |
| IPR020846 | MFS_dom | Domain |
| IPR036259 | MFS_trans_sf | Homologous_superfamily |
Pfam: PF00083
UniProt features (29 total): topological domain 12, transmembrane region 11, splice variant 3, glycosylation site 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q63ZE4-F1 | 87.53 | 0.50 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (2): 56, 102
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 25 (showing top):
GOBP_ORGANIC_ANION_TRANSPORT, GOBP_TRANSMEMBRANE_TRANSPORT, GOMF_TRANSPORTER_ACTIVITY, SRSF9_TARGET_GENES, MIR520D_5P, MIR524_5P, MIR374A_5P, MIR1185_1_3P_MIR1185_2_3P, LET_7F_2_3P, MIR374B_5P, MIR7152_5P, MIR4666B, MIR96_3P, MIR6886_3P, MIR3923
GO Biological Process (2): obsolete organic anion transport (GO:0015711), transmembrane transport (GO:0055085)
GO Molecular Function (1): transmembrane transporter activity (GO:0022857)
GO Cellular Component (1): membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transport | 1 |
| cellular process | 1 |
| transporter activity | 1 |
| transmembrane transport | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
628 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SLC22A10 | SLC67A1 | Q96BI1 | 594 |
| SLC22A10 | OR2L8 | Q8NGY9 | 519 |
| SLC22A10 | MAGEB16 | A2A368 | 512 |
| SLC22A10 | SLCO4C1 | Q6ZQN7 | 508 |
| SLC22A10 | SLCO1A2 | P46721 | 490 |
| SLC22A10 | SLC28A1 | O00337 | 474 |
| SLC22A10 | UROC1 | Q96N76 | 474 |
| SLC22A10 | SLCO3A1 | Q9UIG8 | 472 |
| SLC22A10 | SLC22A23 | A1A5C7 | 459 |
| SLC22A10 | SLCO4A1 | Q96BD0 | 455 |
| SLC22A10 | SLC2A9 | Q9NRM0 | 452 |
| SLC22A10 | FAM187B | Q17R55 | 439 |
| SLC22A10 | SLC22A9 | Q8IVM8 | 436 |
| SLC22A10 | SLC7A13 | Q8TCU3 | 429 |
| SLC22A10 | SLC22A17 | Q8WUG5 | 427 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SLC22A10 | PGRMC1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (22): SLC22A10 (Positive Genetic), ATP13A1 (Affinity Capture-MS), CANX (Affinity Capture-MS), CLGN (Affinity Capture-MS), CLPTM1 (Affinity Capture-MS), DNAJC16 (Affinity Capture-MS), ERLEC1 (Affinity Capture-MS), ERLIN1 (Affinity Capture-MS), ERLIN2 (Affinity Capture-MS), FADS2 (Affinity Capture-MS), FAM8A1 (Affinity Capture-MS), NGLY1 (Affinity Capture-MS), OS9 (Affinity Capture-MS), PGRMC1 (Affinity Capture-MS), PLD3 (Affinity Capture-MS)
ESM2 similar proteins: A0A3Q2IDB4, A0A8B7HA97, A4ZYQ5, A6NK97, G1SZD9, O35956, O57379, O88909, P22732, P23945, P43427, Q0IHM1, Q2KIV1, Q3ZAV1, Q4U2R8, Q4W8A2, Q4W8A3, Q5R9C4, Q5RC45, Q5RCH6, Q5RET7, Q63ZE4, Q66J52, Q6DFR1, Q6NUB3, Q6NYN7, Q6PXP3, Q6T423, Q70BM6, Q76M72, Q76M99, Q80UJ1, Q863Y9, Q864Z3, Q8CFZ5, Q8HY24, Q8IVM8, Q8MK48, Q8N4F4, Q8R0S9
Diamond homologs: A0A3Q2IDB4, A0A8B7HA97, A6NK97, A6QLW8, B2GV36, G1SZD9, O34691, O35956, O57379, O75751, O88446, O88909, Q1RPP5, Q28ES4, Q2KIV1, Q3YAW7, Q3ZAV1, Q4U2R8, Q4W8A2, Q4W8A3, Q5R540, Q5R9C4, Q5RC45, Q5RCH6, Q5RLM2, Q63ZE4, Q66J52, Q66J54, Q6A4L0, Q6NYN7, Q6T423, Q70BM6, Q76M72, Q76M99, Q80UJ1, Q864Z3, Q8CFZ5, Q8HY24, Q8IVM8, Q8MK48
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| HNF1A | “up-regulates quantity by expression” | SLC22A10 | “transcriptional regulation” |
Disease & clinical
Clinical variants and AI predictions
ClinVar
91 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 82 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1462 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:63299040:AGAGG:A | donor_loss | 1.0000 |
| 11:63299041:GAG:G | donor_gain | 1.0000 |
| 11:63299041:GAGGT:G | donor_loss | 1.0000 |
| 11:63299042:AGG:A | donor_loss | 1.0000 |
| 11:63299043:GGT:G | donor_loss | 1.0000 |
| 11:63299044:G:GG | donor_gain | 1.0000 |
| 11:63299044:GTG:G | donor_loss | 1.0000 |
| 11:63299045:TGA:T | donor_loss | 1.0000 |
| 11:63299046:GAG:G | donor_loss | 1.0000 |
| 11:63304890:G:GG | donor_gain | 1.0000 |
| 11:63297413:C:T | donor_gain | 0.9900 |
| 11:63297453:GCCCA:G | donor_gain | 0.9900 |
| 11:63297458:G:GG | donor_gain | 0.9900 |
| 11:63298914:TATCA:T | acceptor_loss | 0.9900 |
| 11:63298915:ATCAG:A | acceptor_gain | 0.9900 |
| 11:63298916:T:G | acceptor_gain | 0.9900 |
| 11:63298916:TCAGG:T | acceptor_loss | 0.9900 |
| 11:63298917:CAG:C | acceptor_loss | 0.9900 |
| 11:63298918:A:T | acceptor_loss | 0.9900 |
| 11:63298918:AGGT:A | acceptor_gain | 0.9900 |
| 11:63298919:G:GC | acceptor_loss | 0.9900 |
| 11:63298919:GGTG:G | acceptor_gain | 0.9900 |
| 11:63299039:TAGAG:T | donor_gain | 0.9900 |
| 11:63299593:G:GG | donor_gain | 0.9900 |
| 11:63299606:GA:G | donor_gain | 0.9900 |
| 11:63304876:G:GT | donor_gain | 0.9900 |
| 11:63304886:ATCA:A | donor_gain | 0.9900 |
| 11:63304887:TCA:T | donor_gain | 0.9900 |
| 11:63297557:A:AG | acceptor_gain | 0.9800 |
| 11:63297558:G:GG | acceptor_gain | 0.9800 |
AlphaMissense
3521 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:63290310:T:A | C49S | 0.979 |
| 11:63290311:G:C | C49S | 0.979 |
| 11:63290283:T:C | F40L | 0.971 |
| 11:63290285:T:A | F40L | 0.971 |
| 11:63290285:T:G | F40L | 0.971 |
| 11:63290436:T:C | F91L | 0.971 |
| 11:63290438:T:A | F91L | 0.971 |
| 11:63290438:T:G | F91L | 0.971 |
| 11:63290172:T:C | F3L | 0.970 |
| 11:63290174:T:A | F3L | 0.970 |
| 11:63290174:T:G | F3L | 0.970 |
| 11:63302480:A:C | S408R | 0.966 |
| 11:63302482:C:A | S408R | 0.966 |
| 11:63302482:C:G | S408R | 0.966 |
| 11:63290511:T:A | C116S | 0.965 |
| 11:63290512:G:C | C116S | 0.965 |
| 11:63290211:T:C | F16L | 0.958 |
| 11:63290213:T:A | F16L | 0.958 |
| 11:63290213:T:G | F16L | 0.958 |
| 11:63290310:T:C | C49R | 0.958 |
| 11:63290525:G:C | W120C | 0.957 |
| 11:63290525:G:T | W120C | 0.957 |
| 11:63304204:C:A | P461H | 0.957 |
| 11:63291552:T:A | C139S | 0.956 |
| 11:63291553:G:C | C139S | 0.956 |
| 11:63290427:T:A | C88S | 0.954 |
| 11:63290428:G:C | C88S | 0.954 |
| 11:63304198:T:C | L459P | 0.954 |
| 11:63297621:A:C | S242R | 0.953 |
| 11:63297623:T:A | S242R | 0.953 |
dbSNP variants (sampled 300 via entrez): RS1000017286 (11:63308558 A>C,G), RS1000057603 (11:63321539 C>A), RS1000118883 (11:63341247 C>T), RS1000123727 (11:63303215 T>A), RS1000136072 (11:63333791 C>A,T), RS1000159001 (11:63330362 G>A,C), RS1000162178 (11:63355314 C>T), RS1000209039 (11:63361049 G>T), RS1000237909 (11:63297024 A>G), RS1000269391 (11:63288775 T>A), RS1000337791 (11:63338494 A>C,G), RS1000352987 (11:63351260 A>G), RS1000369402 (11:63308245 T>C), RS1000405428 (11:63318320 G>C), RS1000439069 (11:63343210 G>A)
Disease associations
OMIM: gene MIM:607580 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
4 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST009733_211 | Urinary metabolite levels in chronic kidney disease | 3.000000e-43 |
| GCST009733_240 | Urinary metabolite levels in chronic kidney disease | 4.000000e-53 |
| GCST009733_97 | Urinary metabolite levels in chronic kidney disease | 2.000000e-11 |
| GCST010512_8 | Serum uric acid levels | 4.000000e-12 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0005116 | urinary metabolite measurement |
| EFO:0004761 | uric acid measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: transporter — Orphan or poorly characterized SLC22 family members
CTD chemical–gene interactions
20 total (human), top 20 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| perfluorooctane sulfonic acid | decreases expression | 2 |
| Benzo(a)pyrene | increases expression, decreases expression | 2 |
| methyleugenol | decreases expression | 1 |
| bisphenol A | affects cotreatment, increases methylation | 1 |
| 2-amino-9H-pyrido(2,3-b)indole | decreases expression | 1 |
| sodium arsenite | increases expression | 1 |
| perfluorooctanoic acid | decreases expression | 1 |
| perfluoro-n-nonanoic acid | decreases expression | 1 |
| Rosiglitazone | decreases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Fulvestrant | affects cotreatment, increases methylation | 1 |
| Troglitazone | decreases expression | 1 |
| Endosulfan | affects cotreatment, decreases expression | 1 |
| Folic Acid | decreases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Silicon Dioxide | increases expression | 1 |
| Tetrachlorodibenzodioxin | affects cotreatment, decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Okadaic Acid | decreases expression | 1 |
Cellosaurus cell lines
2 cell lines: 2 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_D4S6 | HuH7-SLC22A10-KO-c10 | Cancer cell line | Male |
| CVCL_D4S7 | HuH7-SLC22A10-KO-c15 | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.